REQUEST A DEMO
Total
USD $0.00
Search more companies

Aulen Pharma S A (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Aulen Pharma S A Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Aulen Pharma S A is based in Colombia, with the head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on February 20, 2002. Aulen Pharma S A currently employs 30 (2024) people. From the latest financial highlights, Aulen Pharma S A reported a net sales revenue increase of 26.01% in 2023. Its’ total assets recorded a growth of 38.4%.

Headquarters
Cl 101 B 45 A 49
Bogota D.C.; Bogota D.C; Postal Code: 0822

Contact Details: Purchase the Aulen Pharma S A report to view the information.

Basic Information
Total Employees:
Purchase the Aulen Pharma S A report to view the information.
Outstanding Shares:
Purchase the Aulen Pharma S A report to view the information.
Incorporation Date:
February 20, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Aulen Pharma S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
26.01%
Total operating revenue
26.01%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
38.4%
Total equity
66.6%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?